Search results for: 'biopharma deaco and alliance of 2017'
- Did you mean
- biopharma deal and alliance of 2017
- Related search terms
- biopharma deal and alliance of 2015
- biopharma deaco and alliance of 221b
- biopharma deal and alliance of 2016
- 2017 dual alliance review
- biopharma deaf and alliance of 2004
-
Global Animal Health Partnering Terms and Agreements 2017 to 2024October 2024$3,995.00Provides comprehensive understanding and unprecedented access to the animal health agreements entered into by the world's leading biopharma companies.
Learn More -
Current Agreements 12 Month AccessOctober 2024$5,995.00Powerful Intelligence for Dealmakers...
Leading deals and alliances database for the life sciences sector
Learn More -
Global Pharmaceutical Partnering Terms and Agreements 2018-2023March 2023$3,995.00Global Pharmaceutical Partnering Terms and Agreements 2018 to 2023 report provides a detailed understanding and analysis of how and why companies enter pharmaceutical partnering deals.
Learn More -
Companion Diagnostic Collaboration and Licensing Deals 2010-2024May 2024$3,995.00Companion Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2010 to 2024
Learn More -
Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024August 2024$3,995.00The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024 report provides comprehensive understanding and unprecedented access to the discovery stage partnering agreements entered into by the world's leading biopharma companies.
Learn More -
Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024August 2024$3,995.00The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024 provides comprehensive understanding and unprecedented access to clinical stage partnering agreements entered into by the world's leading biopharma companies
Learn More -
Gene Editing Collaboration and Licensing Deals 2016-2024May 2024$3,995.00Gene Editing Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Genitourinary Collaboration and Licensing Deals 2016-2024October 2024$3,995.00Genitourinary Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Royalty Rates in Pharmaceutical and Biotechnology DealsSeptember 2024$3,995.00Essential Benchmark Data for Dealmakers | Global coverage | Updated to 2024 | Over a decade of royalty rates | Deal financials | Contract documents | Royalty rate trends
Learn More -
Biomarker Collaboration and Licensing Deals 2016-2024May 2024$3,995.00Biomarker Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More
